Medical Journals

Development of a Vaccine Against Invasive Pneumococcal Disease Based on Combinations of Virulence Proteins of Streptococcus Pneumoniae.

Authors:
  • Ogunniyi Abiodun D
  • Grabowicz Marcin
  • Briles David E
  • Cook Jan
  • Paton James C

From: School of Molecular and Biomedical Science, The University of Adelaide, SA 5005, Australia.

Infection and immunity

  • Publish Date: Jan 2007
  • ISSN: 0019-9567
  • Volume: 75
  • Issue: 1
  • Pages: 350-7
  • Medium: Print
  • Language: English
  • Citation (JAMA): Ogunniyi Abiodun D, Grabowicz Marcin, Briles David E, et al. Development of a Vaccine Against Invasive Pneumococcal Disease Based on Combinations of Virulence Proteins of Streptococcus Pneumoniae.. Infect. Immun. Jan 2007;75:350-7

Abstract

Current global efforts are focused on exploring alternative pneumococcal vaccine strategies, aimed at addressing the shortcomings of existing formulations, without compromising efficacy. One such strategy involves the use of one or more pneumococcal protein antigens common to all serotypes, to provide cheap, non-serotype-dependent protection. In this study, we evaluated the protective efficacy of immunization of mice with PdB (a pneumolysin toxoid), PspA, PspC (CbpA), PhtB, and PhtE in an invasive-disease model. The antigens were administered in alum adjuvant, either alone or in various combinations. Protection against intraperitoneal challenge with virulent type 2 and 6A strains was assessed in two murine strains. Our findings show that in some situations, different individual proteins gave the best (and worst) protection. However, in many cases, a synergistic/additive effect was seen by using multiple proteins even where the individual proteins showed little value by themselves. For instance, the median survival times for mice immunized with combinations of PdB and PspA, PdB and PspC, or PspA and PspC were significantly longer than those for mice immunized with any of the single antigens. To date, the combination of PdB, PspA, and PspC offers the best protection.

Mesh Headings (Keywords): Animals, Antigens, Bacterial, Bacterial Proteins, Blotting, Western, Enzyme-Linked Immunosorbent Assay, Heat-Shock Proteins, Male, Mice, Mice, Inbred BALB C, Pneumococcal Infections, Pneumococcal Vaccines, Recombinant Fusion Proteins, Streptococcus pneumoniae, Virulence


Check for Full Text / PubMed Unique Identifier (PMID): 17088353


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.